Clarity Pharmaceuticals Ltd.ASX: CU6

First participant imaged in Phase II SAR-Bombesin trial

Oct 6, 2022 at 3:19 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment